Advertisement
Brief report| Volume 28, ISSUE 12, P1058-1060, December 15, 1990

Glycinamide ribonucleotide synthetase activity in lymphocytes from patients with Alzheimer's disease and normal controls

DOI:https://doi.org/10.1016/0006-3223(90)90607-4
Glycinamide ribonucleotide synthetase activity in lymphocytes from patients with Alzheimer's disease and normal controls
Previous ArticleHypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks
Next ArticleTriiodothyronine potentiation of tricyclic antidepressant treatment in patients with panic disorder
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Bartley J.A.
        • Epstein C.J.
        Gene dosage effects for glycinamide ribonucleotide synthetase in human fibroblasts trisomic for chromosome 21.
        Biochem Biophys Res Commun. 1980; 93: 1286-1289
        • Chadefaux B.
        • Allard D.
        • Rethore M.O.
        • et al.
        Assignment of human phosphoglycinamide synthetase locus to region 21q22.1.
        Human Genet. 1984; 66: 190-192
        • Cox D.R.
        • Kawashima H.
        • Vora S.
        • Epstein C.J.
        Regional mapping of SOD-1, PRGS, and PFK-L on human chromosome 21.
        Cytogenet Cell Genet. 1984; 37: 441-442
        • Hagemeijer A.
        • Smit E.M.E.
        Partial trisomy 21, further evidence that trisomy of band 21q22 is essential for Down phenotype.
        Hum Genet. 1977; 38: 15-23
        • Hards R.G.
        • Patterson D.
        Measurement of glycinamide ribonucleotide synthetase activity in intact human fibroblasts and Chinese hamster ovary cells.
        Enzyme. 1986; 35: 117-126
        • Heston L.L.
        • Mastri A.R.
        • Anderson V.E.
        • White J.
        Dementia of the Alzheimer type: Clinical genetics, natural history, and associated conditions.
        Arch Gen Psychiatry. 1981; 38: 1085-1090
        • Marklund S.L.
        • Adolfsson R.
        • Gottfries C.G.
        • Winblad B.
        Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type.
        J Neurol Sci. 1985; 67: 319-325
        • McKhann G.
        • Drachman D.
        • Folstein M.
        • Katzman R.
        • Price D.
        • Stanlow M.
        Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services. Task force of Alzheimer's disease.
        Neurology. 1984; 34: 939-943
        • Scoggin C.H.
        • Bleksan J.
        • Davidson B.J.
        • patterson D.
        Gene expression of glycinamide and ribonucleotide synthetase in Down's syndrome.
        Clin Res. 1980; 28: 31
        • Theinhaus O.L.
        • Cliffe C.
        • Zelman F.P.
        • Bosmann B.B.
        Superoxide dismutase, chromosome 21, and Alzheimer's disease (Letter).
        Biol Psychiatry. 1986; 21: 1106-1107
        • Wisniewski K.E.
        • Howe J.
        • Williams C.G.
        Precocious aging and dementia in patients with Down's syndrome.
        Biol Psychiatry. 1978; 13: 619-627
        • Wisniewski K.E.
        • Wisniewski H.M.
        • Wen G.Y.
        Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.
        Ann Neurol. 1985; 17: 278-282
        • Yates C.M.
        • Simpson J.
        • Maloney A.F.J.
        • Gordon A.
        • Reid A.H.
        Alzheimer-like cholinergic deficiency in Down's syndrome.
        Lancet. 1980; ii: 979

      Article info

      Publication history

      Received in revised form: May 2, 1990
      Received: February 9, 1990

      Identification

      DOI: https://doi.org/10.1016/0006-3223(90)90607-4

      Copyright

      © 1990 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX